4-04-27T04:34:22.381Z","author":{"@type":"Person","name":"Professor Dr. Hans Lentzen","url":"https://merfi-online.com/about"},"description":"CCL17 expression is increased in Colitis-Associated Colorectal Cancer (CAC)\n[?id=65b65649-9584-4ecf-9700-bdd90d9bff85&linkText=Colitis-Associated+Colorectal+Cancer+%28CAC%29]\nMetzger et al. 2022 J Immunol 209 (11): 2227-2238\n\nCCL17 promotes c…\n[?id=65b65649-9584-4ecf-9700-bdd90d9bff85&linkText=Colitis-Associated+Colorectal+Cancer+%28CAC%29]","isAccessibleForFree":false,"hasPart":[{"@type":"WebPageElement","isAccessibleForFree":false,"cssSelector":".tree"},{"@type":"WebPageElement","isAccessibleForFree":false,"cssSelector":".notes"},{"@type":"WebPageElement","isAccessibleForFree":false,"cssSelector":".references"},{"@type":"WebPageElement","isAccessibleForFree":false,"cssSelector":".link"}]}21:T48b,

CCL17 expression is increased in Colitis-Associated Colorectal Cancer (CAC)
Metzger et al. 2022 J Immunol 209 (11): 2227-2238

CCL17 promotes colitis-associated tumorigenesis by influencing the composition of the intestinal microbiome and reducing apoptosis during tumor initiation
Metzger et al. 2022 J Immunol 209 (11): 2227-2238

Single-housed CCL17-deficient mice develop fewer tumors dependent on the microbiota
Metzger et al. 2022 J Immunol 209 (11): 2227-2238

Chemokine (C-C motif) ligand 17 (CCL17)

Navigation

Contents

References (Sources)

AI Chat

Links